Intended for healthcare professionals


FDA warns about metal-on-metal hip replacements

BMJ 2013; 346 doi: (Published 21 January 2013) Cite this as: BMJ 2013;346:f429
  1. Janice Hopkins Tanne
  1. 1New York

The US Food and Drug Administration last week told healthcare professionals that it is updating safety information and recommendations on metal-on-metal hip replacements because of early failures in many cases.

The FDA also issued a proposed order that would require manufacturers of metal-on-metal hip replacements to submit premarket approval applications to prove the safety of the devices. At present the manufacturers have to show only that their devices are similar to ones on the market.

The FDA announcement said, …

View Full Text

Log in

Log in through your institution


* For online subscription